Zai Lab (ZLAB) Research & Development (2018 - 2026)
Zai Lab (ZLAB) posted Research & Development of $65.6 million for Q1 2026, up 6.42% sequentially from $61.6 million in Q4 2025, and up 8.01% YoY from $60.7 million in Q1 2025.
Zai Lab (ZLAB) Research & Development (2018 - 2026) Analysis & Trends
Zai Lab has reported Research & Development for 9 years, with the latest figure at $65.6 million in Q1 2026.
- Quarterly Research & Development rose 8.01% year-over-year to $65.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $225.8 million (down 6.16% YoY) and the FY2025 annual result came in at $220.9 million, down 5.8% from the prior year.
- Research & Development advanced to $65.6 million in Q1 2026 per ZLAB's latest filing, from $61.6 million in the prior quarter.
- Over five years, Research & Development peaked at $99.5 million in Q3 2022 and troughed at $47.9 million in Q3 2025.
- A 5-year average of $63.1 million and a median of $61.6 million in 2024 frame the typical range for Research & Development.
- The widest YoY moves for Research & Development: up 80.48% in 2022, down 73.58% in 2022.
- Over 5 years, Research & Development stood at $66.9 million in 2022, then gained by 22.41% to $81.9 million in 2023, then sank by 36.24% to $52.3 million in 2024, then gained by 17.95% to $61.6 million in 2025, then advanced by 6.42% to $65.6 million in 2026.
- According to Business Quant data, Research & Development over the past three periods registered $65.6 million, $61.6 million, and $47.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 993.80 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.63 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.37 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 394.92 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 612.28 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 1,146.05 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 97.90 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 413.13 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 210.03 Mn |
| 10 | Zai Lab | 2.91 Bn | 2.20 Bn | 58.15 Mn | 61.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 61.77 Mn |
| Mar 31, 2026 | 65.59 Mn |
| Dec 31, 2025 | 61.63 Mn |
| Sep 30, 2025 | 47.93 Mn |
| Jun 30, 2025 | 50.61 Mn |
| Mar 31, 2025 | 60.73 Mn |
| Dec 31, 2024 | 52.25 Mn |
| Sep 30, 2024 | 65.98 Mn |
| Jun 30, 2024 | 61.63 Mn |
| Mar 31, 2024 | 54.65 Mn |
| Dec 31, 2023 | 81.95 Mn |
| Sep 30, 2023 | 58.77 Mn |
| Jun 30, 2023 | 76.68 Mn |
| Mar 31, 2023 | 48.47 Mn |
| Dec 31, 2022 | 66.95 Mn |
| Sep 30, 2022 | 99.52 Mn |
| Jun 30, 2022 | 66.08 Mn |
| Mar 31, 2022 | 53.85 Mn |
| Dec 31, 2021 | 172.09 Mn |
| Sep 30, 2021 | 55.14 Mn |